These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25097287)

  • 1. A suspected case of olanzapine induced hyponatremia.
    Bakhla AK; Guria RT; Kumar A
    Indian J Pharmacol; 2014; 46(4):441-2. PubMed ID: 25097287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine induced hyponatraemia.
    Dudeja SJ; McCormick M; Dudeja RK
    Ulster Med J; 2010 May; 79(2):104-5. PubMed ID: 21116433
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine and delirium: lesson from clinical practice.
    Singh D; Forlano R
    Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine-induced restless leg syndrome: a case report and review of literature.
    Basu A; Kundu S; Khurana H
    Indian J Pharmacol; 2014; 46(4):450-2. PubMed ID: 25097291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-induced hyponatremia in a patient with autism.
    Chiang CL; Lin YH; Hsieh MH
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):699-700. PubMed ID: 24261660
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder.
    Gupta SK; Shwetank B
    Indian J Pharmacol; 2014; 46(4):453-4. PubMed ID: 25097292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of akathisia after switching from branded to generic high-dose olanzapine.
    Goldberg JF
    J Clin Psychiatry; 2012 Apr; 73(4):497. PubMed ID: 22579148
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.
    Vucicevic Z; Degoricija V; Alfirevic Z; Vukicevic-Badouin D
    Int J Clin Pharmacol Ther; 2007 May; 45(5):289-92. PubMed ID: 17542351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electroconvulsion therapy for neuroleptic malignant syndrome].
    Buggenhout S; Vandenberghe J; Sienaert P
    Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-injection syndrome and olanzapine pamoate: A severe case report].
    Descusse A; Chebili S; Artiges E
    Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal water intoxication during olanzapine treatment: a case report.
    Nagasawa S; Yajima D; Torimitsu S; Abe H; Iwase H
    Leg Med (Tokyo); 2014 Mar; 16(2):89-91. PubMed ID: 24388043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin rash occurring with olanzapine pamoate, but not with oral olanzapine, in a male with juvenile idiopathic arthritis.
    Solfanelli A; Curto M; Dimitri-Valente G; Kotzalidis GD; Gasperoni C; Sani G; Manfredi G; Rapinesi C; Comparelli A; Girardi P
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):232-4. PubMed ID: 23607414
    [No Abstract]   [Full Text] [Related]  

  • 15. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression.
    Weissman J; Flint A; Meyers B; Ghosh S; Mulsant B; Rothschild A; Whyte E;
    Psychiatry Res; 2012 May; 197(3):221-6. PubMed ID: 22464991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
    Kang SG; Lee HJ; Kim L
    J Psychopharmacol; 2009 Jul; 23(5):597-601. PubMed ID: 18562412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly developing hyperglycemia during treatment with olanzapine.
    Kohen I; Gampel M; Reddy L; Manu P
    Ann Pharmacother; 2008 Apr; 42(4):588-91. PubMed ID: 18364401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.